Hyperbaric Oxygen Therapy for Multiple Sclerosis

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hyperbaric oxygen therapy for multiple sclerosis.

Multiple sclerosis (MS) is a chronic, inflammatory, and degenerative neurological illness with no cure. It has been suggested that Hyperbaric Oxygen Therapy (HBO(2)T) may slow or reverse the progress of the disease. This article summarizes the clinical evidence for the use of HBO(2)T in the treatment of MS. We conducted a literature review focused on the interaction of hyperbaric oxygenation an...

متن کامل

Hyperbaric oxygen therapy in multiple sclerosis.

In his editorial last fall, Dr Jacoby 1 expressed the feeling that it was time to take a stand against the use of hyperbaric oxygen (HBO2) treatment for patients with multiple sclerosis (MS). However, the Department of Health in the UK accepts low-pressure hyperbaric facilities for patients with multiple sclerosis and other neurological diseases. Over the past 20 years, a UK Charity has provide...

متن کامل

HYPERBARIC OXYGEN THERAPY FOR MULTIPLE SCLEROSIS RELAPSE Protocol

Specific Aim 2: To determine whether use of hyperbaric oxygen impacts MRI parameters. MRI parameters will be evaluated at baseline and 6 months to determine: 2a) Thalamic volume loss 2b) Magnetization transfer ratio (MTR) change in baseline lesions. 2c) Magnetization transfer (MT) histogram whole brain and normal appearing brain tissue change (white matter and gray matter). 2d) Accumulation of ...

متن کامل

Treatment of multiple sclerosis with hyperbaric oxygen therapy.

Despite considerable research effort there is little controlled evidence that a course of hyperbaric oxygen therapy (HBO2T) results in any benefit for patients with multiple sclerosis (MS). The great majority of randomized trials involved investigating a course of 20 treatments at pressures between 1.75 and 2.5 atm abs daily for 60-120 min over 4 wk against a placebo regimen. None has tested th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: CNS Neuroscience & Therapeutics

سال: 2010

ISSN: 1755-5930,1755-5949

DOI: 10.1111/j.1755-5949.2009.00129.x